TNFSF10 and cancer: For example, TRAIL fusion with the ACDCRGDCFC peptide (RGD-L-TRAIL) specifically bounded to microvascular endothelial cells and showed enhanced apoptosis-inducing activity in αvβ3 and αvβ5 integrin-positive cancer cells [31].